Diagnostic study demonstrates accurate detection of acute rejection in heart transplant recipients, highlighting its potential as a noninvasive monitoring tool.
This novel dd-cfDNA test detects AR in HTx recipients with good accuracy and holds promise as a noninvasive test for AR in HTx recipients.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: